25 May 2013
Keywords: Belarus pharma plant, Russian investor, Belbiopharm, Dialek, Grindeks
Article | 09 March 2011
Vladimir Bryntsalov, one of Russia’s richest businessman, and the Belarusian Belbiopharm state concern, may invest up to $120 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.